Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

NADPH Producing Enzymes as Promising Drug Targets for Chagas Disease

Full text
Author(s):
Cordeiro, Artur T.
Total Authors: 1
Document type: Review article
Source: Current Medicinal Chemistry; v. 26, n. 36, p. 6564-6571, 2019.
Web of Science Citations: 1
Abstract

Reduced Nicotinamide Adenine Dinucleotide Phosphate (NADPH) is a cofactor used in different anabolic reactions, such as lipid and nucleic acid synthesis, and for oxidative stress defense. NADPH is essential for parasite growth and viability. In trypanosomatid parasites, NADPH is supplied by the oxidative branch of the pentose phosphate pathway and by enzymes associated with the citric acid cycle. The present article will review recent achievements that suggest glucose-6-phosphate dehydrogenase and the cytosolic isoform of the malic enzyme as promising drug targets for the discovery of new drugs against nypanosoma cruzi and T. brucei. Topics involving an alternative strategy in accelerating T. cruzi drug-target validation and the concept of drug-target classification will also be revisited. (AU)

FAPESP's process: 16/14271-4 - Optimization G6PDH inhibitors towards the development of drugs against Chagas Diseases.
Grantee:Artur Torres Cordeiro
Support Opportunities: Regular Research Grants